Asupardo, Ricthel .

HRN: 23-60-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
CEFUROXIME 750MG (VIAL)
01/26/2024
02/02/2024
IV
750mg
Q8
UTI
Rejected 
01/26/2024
CEFUROXIME 1.5GM (VIAL)
01/26/2024
02/02/2024
IV
1.5gram
Q8
UTI
Waiting Final Action 
01/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/27/2024
02/03/2024
IV
500
Q8
Tc Acute Pancreatitis
Waiting Final Action 
01/28/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/28/2024
02/04/2024
IV
4.5
Loading Dose
Sepsis
Waiting Final Action 
01/28/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/28/2024
02/04/2024
IV
2.25
Q8
Sepsis
Waiting Final Action 
01/28/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/28/2024
01/28/2024
IV
4.5g
Loading Dose
Sepsis
Waiting Final Action 
01/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/31/2024
02/07/2024
IV
2.25g
Q6hr
Sepsis
Waiting Final Action 
01/31/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/31/2024
02/07/2024
IV
500mg
Q6hr
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: